Chlorhexidine

Chlorhexidine

SCHEMBL1898352

CCO.N=C(NCCCCCCNC(=N)NC(=N)Nc1ccc(Cl)cc1)NC(=N)Nc1ccc(Cl)cc1

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Chlorhexidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
CNR1 P21554 2/20 0.40
SLC6A3 Q01959 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
HDAC8 Q9BY41 1/20 0.40
EPHX1 P07099 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.39
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Chlorhexidine SCHEMBL14603395 0.94 LMNA (0.48) LMNASMN1; SMN2CNR1SLC6A3MEN1
Chlorhexidine SCHEMBL3984 0.94 LMNA (0.46) LMNASMN1; SMN2CNR1SLC6A3MEN1
Chlorhexidine SCHEMBL1551122 0.94 LMNA (0.46) LMNASMN1; SMN2CNR1SLC6A3MEN1
SCHEMBL6365499 0.94 LMNA (0.46) LMNASMN1; SMN2CNR1SLC6A3MEN1
Chlorhexidine SCHEMBL1550787 0.94 LMNA (0.46) LMNASMN1; SMN2CNR1SLC6A3MEN1
SCHEMBL3826641 0.93 LMNA (0.55) LMNASMN1; SMN2EPHX1ALDH1A1HTT
Chlorhexidine SCHEMBL21680261 0.93 LMNA (0.55) LMNASMN1; SMN2EPHX1ALDH1A1HTT
SCHEMBL12522772 0.93 LMNA (0.55) LMNASMN1; SMN2EPHX1ALDH1A1HTT
Chlorhexidine SCHEMBL23533285 0.93 LMNA (0.43) LMNASMN1; SMN2CNR1SLC6A3MEN1
Chlorhexidine SCHEMBL6433032 0.92 LMNA (0.45) LMNASMN1; SMN2CNR1SLC6A3MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-214340262-U Anti-fogging mask 中国人民解放军陆军特色医学中心 2021-10-08 CN claimed
CN-214259831-U Nursing bag for transfusion port 河南省人民医院 2021-09-24 CN claimed
CN-111202088-A Chlorhexidine acetate disinfectant and preparation method and application thereof 吉林云飞医药有限公司 2020-05-29 CN claimed
US-5753246-A Packaged germicidal towelette, sanitation kit and method for promoting hygiene PETERS MARLIN W (US) 1998-05-19 US claimed
CN-112368778-B Method and use for providing educational guidance for peripheral IV therapy 贝克顿·迪金森公司 2024-07-16 CN disclosed
WO-2023131355-A1 WATER-SOLUBLE CHLORHEXIDINE ANTIBACTERIAL, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF 江南大学 2023-07-13 WO disclosed
CN-115881288-B Vein catheterization management system 四川省肿瘤医院 2023-05-12 CN disclosed
CN-115881288-A Vein catheterization management system 四川省肿瘤医院 2023-03-31 CN disclosed
CN-114391550-B Water-soluble chlorhexidine antibacterial agent and preparation method and application thereof 江南大学 2022-11-22 CN disclosed
CN-114391550-A Water-soluble chlorhexidine antibacterial agent and preparation method and application thereof 江南大学 2022-04-26 CN disclosed
CN-214475487-U Infusion connects disinfection reminding device 武汉大学 2021-10-22 CN disclosed
CN-214259831-U Nursing bag for transfusion port 河南省人民医院 2021-09-24 CN disclosed
US-20020061286-A1 Wipe with improved cleansing BANK OF AMERICA, N.A., AS COLLATERAL AGENT 2002-05-23 US disclosed
WO-2002000817-A1 WIPE WITH IMPROVED CLEANSING PLAYTEX PRODUCTS, INC. (US) 2002-01-03 WO disclosed
US-6086578-A Method for skin rejuvenation ZAKRYTOYE AKTSIONERNOYE OBSCHESTO "OSTMEDKONSALT" (RU) 2000-07-11 US disclosed
US-5753246-A Packaged germicidal towelette, sanitation kit and method for promoting hygiene PETERS MARLIN W (US) 1998-05-19 US disclosed
US-5753246-A Packaged germicidal towelette, sanitation kit and method for promoting hygiene PETERS MARLIN W (US) 1998-05-19 US disclosed
US-4981678-A ALCOHOLIC CHLORHEXIDINE SOLTEC RESEARCH PTY., LTD. (AU) 1991-01-01 US disclosed
US-4915934-A CORROSION INHIBITOR CONNETICS AUSTRALIA PTY. LTD. (AU) 1990-04-10 US disclosed
US-4301803-A Balloon catheter KURARAY CO., LTD. (JP) 1981-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020061286-A1 Wipe with improved cleansing CENPE, CHAT, PHOSPHO1 LMNA 3296/4885SMN1; SMN2 895/4885CNR1 2094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.